Physician profile
Galina Kletsman
NPI 1528003019
$1,049.03
in general payments reported to CMS, 2019-2025
18 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $86.18 · 2021: $122 · 2022: $162 · 2023: $199 · 2024: $188 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $518.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $162.32 | 2019-2023 | |
| Abbvie INC. | $122.03 | 2021-2024 | |
| Ironwood Pharmaceuticals, INC | $121.37 | 2021-2024 | Linzess |
| Nestle Healthcare Nutrition INC. | $119.63 | 2021-2023 | |
| Aimmune Therapeutics, INC. | $63.29 | 2024-2025 | Zenpep |
| Allergan, INC. | $62.19 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $60.72 | 2022-2025 | Eliquis |
| Amgen INC. | $49.93 | 2020 | |
| Azurity Pharmaceuticals, INC. | $42.90 | 2023-2025 | Edarbi, Edarbi |
| Pfizer INC. | $36.30 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $31.50 | 2019 | |
| Ardelyx, INC. | $30.00 | 2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $29.96 | 2024 | |
| Lilly USA, LLC | $25.19 | 2023 | Mounjaro |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $22.09 | 2025 | Topical Oxygen Chamber For Extremities |
| Astrazeneca Pharmaceuticals Lp | $20.09 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Galina Kletsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.